Rare diseases
Investigational molecules
Locations
Back to Spain57 clinical trials in Gijon, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of icotrokinra for adults with moderately to severely active Crohn's disease
SpainTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
SpainStudy of Acalabrutinib with R-CHOP for Patients with Untreated Mantle Cell Lymphoma in Spain
SpainStudy of Zilovertamab Vedotin and Drug Combination for Untreated Diffuse Large B-Cell Lymphoma Patients
SpainStudy on Ursodeoxycholic Acid to Prevent Recurrence of Acute Biliary Pancreatitis in Patients After Gallstone-Related Episode
SpainStudy on Controlling Coronary Risk Factors and Platelet Aggregation Using Ramipril, Acetylsalicylic Acid, and Atorvastatin Calcium Trihydrate in Patients with Heart Disease
SpainStudy on the Effectiveness of Clopidogrel, Prasugrel, and Ticagrelor in Patients with Coronary Acute Syndrome Using VerifyNow Device
SpainStudy on Colchicine and Opium for Preventing Heart and Kidney Issues in Patients with Moderate Chronic Kidney Disease
SpainStudy on the Safety and Effectiveness of Linvoseltamab, Sarilumab, and Dexamethasone in Adults with Relapsed or Refractory AL Amyloidosis
SpainStudy on Donepezil for Mild Cognitive Impairment in Parkinson's Disease Patients
SpainStudy on Short-term Interruption vs. Continuous Anticoagulation with Apixaban in Patients Undergoing Colorectal Polypectomy
SpainStudy on the Safety of Continuing Apixaban, Clopidogrel, and Rivaroxaban During Polyp Removal in Patients on Antiplatelet or Anticoagulant Therapy
SpainThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on multiple myeloma and various lymphomas, including innovative combination therapies and novel treatment approaches for previously untreated and relapsed/refractory cases.
Studies evaluating breakthrough treatments like acalabrutinib, belantamab mafodotin, and linvoseltamab.
Clinical investigations targeting various digestive system conditions, with particular emphasis on pancreatic diseases and inflammatory bowel conditions.
Research includes both therapeutic interventions and surgical approaches for optimal patient outcomes.
Innovative studies examining treatments for coronary artery conditions and vascular events, with focus on both preventive measures and therapeutic interventions.
Investigations into beta-blockers, antiplatelet agents, and colchicine for various cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
